Cargando…
T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Association for the Study of the Liver. Published by Elsevier B.V.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252356/ http://dx.doi.org/10.1016/S0168-8278(22)00518-9 |
| _version_ | 1784740245352218624 |
|---|---|
| author | Murray, Sam Longet, Stephanie Tipton, Tom Londoño, Maria Carlota Pose, Elisa Laidlaw, Stephen Nguyen, Dung Meacham, Georgina Lim, Zixiang Dimitriadis, Stavros Irwin, Sophie Cook, Jonathan Iavarone, Massimo Lampertico, Pietro Hernandez-Gea, Virginia Garcia Pagan, Juan Carlos zur Wiesch, Julian Schulze Sterneck, Martina Russo, Francesco Paolo Satsangi, Jack Dunachie, Susanna Klenerman, Paul Goodyear, Carl McInnes, Iain B. Ginès, Pere Carroll, Miles Marjot, Thomas Barnes, Eleanor |
| author_facet | Murray, Sam Longet, Stephanie Tipton, Tom Londoño, Maria Carlota Pose, Elisa Laidlaw, Stephen Nguyen, Dung Meacham, Georgina Lim, Zixiang Dimitriadis, Stavros Irwin, Sophie Cook, Jonathan Iavarone, Massimo Lampertico, Pietro Hernandez-Gea, Virginia Garcia Pagan, Juan Carlos zur Wiesch, Julian Schulze Sterneck, Martina Russo, Francesco Paolo Satsangi, Jack Dunachie, Susanna Klenerman, Paul Goodyear, Carl McInnes, Iain B. Ginès, Pere Carroll, Miles Marjot, Thomas Barnes, Eleanor |
| author_sort | Murray, Sam |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9252356 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Association for the Study of the Liver. Published by Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92523562022-07-05 T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network Murray, Sam Longet, Stephanie Tipton, Tom Londoño, Maria Carlota Pose, Elisa Laidlaw, Stephen Nguyen, Dung Meacham, Georgina Lim, Zixiang Dimitriadis, Stavros Irwin, Sophie Cook, Jonathan Iavarone, Massimo Lampertico, Pietro Hernandez-Gea, Virginia Garcia Pagan, Juan Carlos zur Wiesch, Julian Schulze Sterneck, Martina Russo, Francesco Paolo Satsangi, Jack Dunachie, Susanna Klenerman, Paul Goodyear, Carl McInnes, Iain B. Ginès, Pere Carroll, Miles Marjot, Thomas Barnes, Eleanor J Hepatol ORAL PRESENTATIONS: Friday 24 June: Liver Immunology European Association for the Study of the Liver. Published by Elsevier B.V. 2022-07 2022-07-04 /pmc/articles/PMC9252356/ http://dx.doi.org/10.1016/S0168-8278(22)00518-9 Text en Copyright © 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | ORAL PRESENTATIONS: Friday 24 June: Liver Immunology Murray, Sam Longet, Stephanie Tipton, Tom Londoño, Maria Carlota Pose, Elisa Laidlaw, Stephen Nguyen, Dung Meacham, Georgina Lim, Zixiang Dimitriadis, Stavros Irwin, Sophie Cook, Jonathan Iavarone, Massimo Lampertico, Pietro Hernandez-Gea, Virginia Garcia Pagan, Juan Carlos zur Wiesch, Julian Schulze Sterneck, Martina Russo, Francesco Paolo Satsangi, Jack Dunachie, Susanna Klenerman, Paul Goodyear, Carl McInnes, Iain B. Ginès, Pere Carroll, Miles Marjot, Thomas Barnes, Eleanor T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title | T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title_full | T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title_fullStr | T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title_full_unstemmed | T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title_short | T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network |
| title_sort | t cell and humoral immune response to multiple sars-cov-2 variants including omicron (b1.1.529) after two doses of covid-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the easl covid-hep network |
| topic | ORAL PRESENTATIONS: Friday 24 June: Liver Immunology |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252356/ http://dx.doi.org/10.1016/S0168-8278(22)00518-9 |
| work_keys_str_mv | AT murraysam tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT longetstephanie tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT tiptontom tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT londonomariacarlota tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT poseelisa tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT laidlawstephen tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT nguyendung tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT meachamgeorgina tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT limzixiang tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT dimitriadisstavros tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT irwinsophie tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT cookjonathan tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT iavaronemassimo tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT lamperticopietro tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT hernandezgeavirginia tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT garciapaganjuancarlos tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT zurwieschjulianschulze tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT sterneckmartina tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT russofrancescopaolo tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT satsangijack tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT dunachiesusanna tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT klenermanpaul tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT goodyearcarl tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT mcinnesiainb tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT ginespere tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT carrollmiles tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT marjotthomas tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork AT barneseleanor tcellandhumoralimmuneresponsetomultiplesarscov2variantsincludingomicronb11529aftertwodosesofcovid19vaccineinpatientswithcirrhosisandliverdiseasesrequiringimmunosuppressiondatafromtheeaslcovidhepnetwork |